Novo Holdings A/S as of June 30, 2026
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 25 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Edgewise Therapeutics (EWTX) | 12.6 | $217M | 5.4M | 40.63 | |
| Asml Holding N V N Y Registry Shs (ASML) | 11.0 | $189M | 95k | 1989.44 | |
| Hemab Therapeutics Hldgs Com Shs | 8.9 | $154M | 4.2M | 36.73 | |
| Brookfield Corp Cl A Ltd Vt Sh (BN) | 8.7 | $150M | 3.5M | 42.77 | |
| Maplight Therapeutics (MPLT) | 7.7 | $132M | 3.7M | 35.84 | |
| Mirum Pharmaceuticals (MIRM) | 7.6 | $132M | 1.1M | 117.07 | |
| Avalyn Pharmaceuticals Com Shs | 7.4 | $128M | 3.9M | 32.92 | |
| salesforce (CRM) | 3.6 | $62M | 393k | 156.66 | |
| Arrivent Biopharma (AVBP) | 3.0 | $52M | 1.5M | 34.74 | |
| Enliven Therapeutics (ELVN) | 2.9 | $51M | 1.0M | 50.75 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.9 | $49M | 1.3M | 37.42 | |
| Pharvaris N V (PHVS) | 2.8 | $48M | 1.4M | 34.58 | |
| Floor & Decor Hldgs Cl A (FND) | 2.7 | $47M | 797k | 59.36 | |
| Vaxcyte (PCVX) | 2.7 | $47M | 800k | 58.13 | |
| 4d Molecular Therapeutics In (FDMT) | 2.5 | $43M | 3.2M | 13.30 | |
| Miragen Therapeutics (VRDN) | 2.3 | $39M | 2.1M | 18.37 | |
| Celldex Therapeutics Com New (CLDX) | 2.2 | $38M | 1.0M | 37.21 | |
| Alumis (ALMS) | 1.8 | $31M | 1.1M | 28.14 | |
| Xenon Pharmaceuticals (XENE) | 1.7 | $29M | 485k | 60.36 | |
| Alibaba Group Hldg Sponsored Ads (BABA) | 1.4 | $25M | 257k | 95.98 | |
| Dyne Therapeutics (DYN) | 1.2 | $21M | 960k | 22.21 | |
| Bridgebio Oncology Therapeut Com New (BBOT) | 1.0 | $17M | 2.3M | 7.62 | |
| Insmed Com Par $.01 (INSM) | 0.7 | $13M | 121k | 106.62 | |
| Marqeta Class A Com (MQ) | 0.4 | $7.2M | 442k | 16.24 | |
| Lanzatech Global Com New (LNZA) | 0.1 | $1.1M | 158k | 6.82 |
